Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/21/20 → 1/21/26 |
Funding
- Hoosier Cancer Research Network, Inc. ((OE) Prot #BTCRC-BRE18-337 // (OE) Prot #BTCRC-BRE18-337)
- Pfizer Inc. ((OE) Prot #BTCRC-BRE18-337 // (OE) Prot #BTCRC-BRE18-337)
Prot #BTCRC-BRE18-337: Phase 2 Trial with Safety Run-In of Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers Big Ten Cancer Research Consortium BTCRC-BRE18-337
- Shah, Ami N (PD/PI)
Project: Research project